Open Beta
TREN
MetriLume
TREN

US marketsIRD

SEC-sourced researchBeta

IRD

Opus Genetics, Inc.

Company comparison ↗

Data passport

CIK
0001228627
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 10,992,000.0000 USD; December 2025: 14,196,000.0000 USD14.2M USD0 USD0December 2024December 2025
IRD · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202410,992,000.0000Mar 12, 2026
December 202514,196,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202514,196,000.0000-49,591,000.0000-35,253,000.000050,243,000.000034,895,000.0000Mar 12, 2026
December 202410,992,000.0000-57,532,000.0000-25,576,000.000036,862,000.000011,295,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$14.2MDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$10.99MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss-$49.59MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$35.25MDecember 2025Mar 12, 202610-K
Total assetsAssets$50.24MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$34.9MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗